CYTOKINE ELEVATIONS IN CRITICALLY ILL INFANTS WITH SEPSIS AND NECROTIZING ENTEROCOLITIS

被引:161
作者
HARRIS, MC
COSTARINO, AT
SULLIVAN, JS
DULKERIAN, S
MCCAWLEY, L
CORCORAN, L
BUTLER, S
KILPATRICK, L
机构
[1] UNIV PENN, CHILDRENS HOSP PHILADELPHIA, SCH MED, DIV ALLERGY IMMUNOL & INFECT DIS, PHILADELPHIA, PA 19104 USA
[2] UNIV PENN, CHILDRENS HOSP PHILADELPHIA, SCH MED, DEPT PEDIAT, PHILADELPHIA, PA 19104 USA
[3] UNIV PENN, CHILDRENS HOSP PHILADELPHIA, SCH MED, DEPT ANESTHESIA & CRIT CARE MED, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1016/S0022-3476(94)70264-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We hypothesized that plasma levels of cytokines such as interleukin-6 and tumor necrosis factor (TNF) are elevated in critically ill infants with sepsis and necrotizing enterocolitis (NEC) and that the magnitude of their elevation is correlated with mortality rate. We measured plasma levels of interleukin-6 and TNF in 62 newborn infants with suspected sepsis or NEC. Eighteen infants had bacterial sepsis, 9 had bacterial sepsis plus NEC, and 15 had NEC but negative culture results. Twenty comparably ill infants with negative results on culture of systemic specimens served as study control subjects. Interleukin-6 levels were five- to tenfold higher in infants with bacterial sepsis plus NEC at the onset of disease than in infants with bacterial sepsis alone, in infants with NEC but negative culture results, and in control infants (p < 0.01). These differences persisted throughout the 48-hour study period. Interleukin-6 levels,were also significantly higher in nonsurvivors than in survivors (p < 0.001). In contrast, plasma TNF values were not consistently increased in any of the groups. We conclude that plasma interleukin-6 is a more reliable indicator of bacterial sepsis and NEC than plasma TNF and may identify infants who might benefit from immunotherapeutic strategies.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 25 条
[1]   CIRCULATING INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR IN SEPTIC SHOCK AND EXPERIMENTAL ENDOTOXIN FEVER [J].
CANNON, JG ;
TOMPKINS, RG ;
GELFAND, JA ;
MICHIE, HR ;
STANFORD, GG ;
VANDERMEER, JWM ;
ENDRES, S ;
LONNEMANN, G ;
CORSETTI, J ;
CHERNOW, B ;
WILMORE, DW ;
WOLFF, SM ;
BURKE, JF ;
DINARELLO, CA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01) :79-84
[2]  
CANNON JG, 1988, LYMPHOKINE RES, V7, P457
[3]   ROLE OF PLATELET ACTIVATING FACTOR AND TUMOR NECROSIS FACTOR-ALPHA IN NEONATAL NECROTIZING ENTEROCOLITIS [J].
CAPLAN, MS ;
SUN, XM ;
HSUEH, W ;
HAGEMAN, JR .
JOURNAL OF PEDIATRICS, 1990, 116 (06) :960-964
[4]   PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS [J].
DEBETS, JMH ;
KAMPMEIJER, R ;
VANDERLINDEN, MPMH ;
BUURMAN, WA ;
VANDERLINDEN, CJ .
CRITICAL CARE MEDICINE, 1989, 17 (06) :489-494
[5]   TUMOR-NECROSIS-FACTOR IN THE PATHOPHYSIOLOGY OF INFECTION AND SEPSIS [J].
FONG, Y ;
LOWRY, SF .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 55 (02) :157-170
[6]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 IN THE SERUM OF CHILDREN WITH SEVERE INFECTIOUS PURPURA [J].
GIRARDIN, E ;
GRAU, GE ;
DAYER, JM ;
ROUXLOMBARD, P ;
LAMBERT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (07) :397-400
[7]   TUMOR NECROSIS FACTOR IN NEONATAL LISTERIOSIS - A CASE-REPORT [J].
GIRARDIN, E ;
BERNER, M ;
GRAU, GE ;
DAYER, JM ;
ROUXLOMBARD, P ;
SUTER, S .
EUROPEAN JOURNAL OF PEDIATRICS, 1989, 148 (07) :644-645
[8]  
GROLL AH, 1992, PEDIATR INFECT DIS J, V11, P496
[9]  
HACK CE, 1989, BLOOD, V74, P1704
[10]  
HARRIS MC, 1993, WORKBOOK PRACTICAL N, P227